The introduction of nicotinamide being a nicotine substitute in e-cigarette and smokeless products and solutions represents an important regulatory challenge for your FDA. Nicotinamide doesn't have nicotinic receptor agonist activity and is understood to work as a sedative at large dosages6. The claims produced by Nicotine River, ECBlend, and other